Teacher Retirement System of Texas’s Mirum Pharmaceuticals MIRM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$449K Sell
4,856
-713
-13% -$67.1K ﹤0.01% 1122
2025
Q4
$440K Sell
5,569
-3,514
-39% -$252K ﹤0.01% 1278
2025
Q3
$666K Sell
9,083
-820
-8% -$52.1K ﹤0.01% 1405
2025
Q2
$504K Buy
9,903
+215
+2% +$9.57K ﹤0.01% 1537
2025
Q1
$436K Sell
9,688
-925
-9% -$43.6K ﹤0.01% 1570
2024
Q4
$439K Buy
10,613
+1,748
+20% +$72.8K ﹤0.01% 1294
2024
Q3
$346K Buy
8,865
+1,647
+23% +$65.7K ﹤0.01% 1305
2024
Q2
$247K Buy
+7,218
New +$189K ﹤0.01% 1432
2024
Q1
Sell
-137,216
Closed -$4.05M 1762
2023
Q4
$4.05M Buy
137,216
+130,210
+1,859% +$3.94M 0.03% 421
2023
Q3
$221K Buy
+7,006
New +$192K ﹤0.01% 1705

Other funds holding MIRM

Teacher Retirement System of Texas's MIRM Position: Q1 2026 in Review

Teacher Retirement System of Texas reduced its Mirum Pharmaceuticals (MIRM) stake by 13% in Q1 2026, selling an estimated $67.1K and leaving 4,856 shares worth $449K. The position accounts for ﹤0.01% of the portfolio, ranked #1122.

Teacher Retirement System of Texas first reported a position in MIRM in Q3 2023 and has held it in 10 quarters since. The position peaked at $4.05M in Q4 2023. 311 funds tracked by Wall St. Rank hold MIRM as of Q1 2026.

  • Teacher Retirement System of Texas held 4,856 shares of Mirum Pharmaceuticals worth $449K as of Q1 2026.
  • Teacher Retirement System of Texas sold 713 Mirum Pharmaceuticals shares in Q1 2026, an estimated $67.1K.
  • Mirum Pharmaceuticals made up ﹤0.01% of Teacher Retirement System of Texas's portfolio in Q1 2026, its #1122 holding.
  • Teacher Retirement System of Texas first reported a position in Mirum Pharmaceuticals in Q3 2023 and has held it in 10 quarters since.
  • Teacher Retirement System of Texas's Mirum Pharmaceuticals position peaked at $4.05M in Q4 2023.
  • 311 funds tracked by Wall St. Rank held Mirum Pharmaceuticals as of Q1 2026.

Based on Teacher Retirement System of Texas's 13F filing for Q1 2026, filed 30 Apr 2026.